Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amyris Inc    AMRS

AMYRIS INC

(AMRS)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/24/2019 Date
4.09(c) 4.12(c) 4.24(c) 4.21(c) 4.02(c) Last
1 333 850 630 048 723 589 840 171 904 868 Volume
-3.54% +0.73% +2.91% -0.71% -4.51% Change
More quotes
Financials (USD)
Sales 2019 225 M
EBIT 2019 -14,6 M
Net income 2019 -36,6 M
Debt 2019 -
Yield 2019 -
Sales 2020 330 M
EBIT 2020 42,2 M
Net income 2020 20,2 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 14,89
Capi. / Sales2019 1,28x
Capi. / Sales2020 0,88x
Capitalization 289 M
More Financials
Company
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and... 
Sector
Specialty Chemicals
Calendar
08/05Earnings Release
More about the company
Latest news on AMYRIS INC
06:36aAMYRIS : Appoints Two New Board Members with Significant Experience in Building ..
AQ
05/24AMYRIS : Appoints Two New Board Members with Significant Experience in Building ..
AQ
05/23AMYRIS : Teams Up with Model and Businesswoman Rosie Huntington-Whiteley as Bran..
AQ
05/22AMYRIS : Announces the Execution of Strategic Supply Agreements with Raizen, the..
AQ
05/22AMYRIS : Announces the Execution of Strategic Supply Agreements with Razen, the ..
AQ
05/21AMYRIS : to Present at B. Riley FBR 20th Annual Institutional Investor Conferenc..
AQ
05/21AMYRIS : Announces the Execution of Strategic Supply Agreements with Raízen, the..
AQ
05/21AMYRIS : Announces Receipt of $10 Million Payment from LAVVAN for Delivering on ..
AQ
05/20AMYRIS, INC. : Change in Directors or Principal Officers, Shareholder Director N..
AQ
05/20AMYRIS : Receives Notification of Deficiency from Nasdaq Related to Delayed Quar..
AQ
More news
Sector news : Industrial Biotechnology Chemicals
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/17Global private equity firms to bid for Hitachi's chemical unit - sources
RE
05/15PATRICK THOMAS : Agilent Technologies Shares Fall After Slower Sales From China
DJ
05/14MERCK : sees currencies supporting 2019 outlook
RE
05/07GLOBAL MARKETS LIVE : Alstom, Iliad, EuropaCorp, ArcelorMittal, Airbus, Anadarko..
More sector news : Industrial Biotechnology Chemicals
Chart AMYRIS INC
Duration : Period :
Amyris Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMYRIS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,0 $
Spread / Average Target 174%
EPS Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey Mark Duyk Chairman
Eduardo Alvarez Chief Operating Officer
Kathleen Valiasek Chief Financial Officer
Joel Cherry President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS INC20.36%289
ECOLAB INC.23.84%52 598
HENKEL-13.77%39 059
GIVAUDAN16.26%24 378
SIKA AG22.27%21 553
EMS-CHEMIE HOLDING30.09%14 178